Mechanism of the chronotropic effects of prostacyclin in the dog: comparison with the actions of prostaglandin E2
- PMID: 6988574
Mechanism of the chronotropic effects of prostacyclin in the dog: comparison with the actions of prostaglandin E2
Abstract
The cardiovascular effects of prostaglandin (PG) I2 and E2 were investigated in the anesthetized dog and in the isolated blood perfused canine atrial preparation cross-circulated by the donor dog. When small doses of PGI2 (less than .01 microgram/kg) or PGE2 (1 microgram/kg) were injected into the jugular vein of the donor dog, there was a slight fall in blood pressure (5-10 mm Hg) and a slight degree of tachycardia (2-6 beats/min). However, larger doses of PGI2 (1-10 microgram/kg) or PGE2 (3-10 microgram/kg) produced hypotension that was associated with marked bradycardia. The bradycardia produced by both PGE2 and PGI2 in the donor dog was blocked by either atropine pretreatment or vagotomy and was inverted to tachycardia. The tachycardia was significantly suppressed by propranolol. Administration of PGI2 either to the donor dog or directly into the sinus node arterial cannula did not alter the atrial rate or developed tension in the isolated blood perfused atrial preparation. In contrast, when PGE2 was given in larger doses (10 microgram/kg) to the donor dog, the sinus rate and developed tension in the isolated atria were increased. This effect was markedly diminished after propranolol treatment. Administration of PGE2 (1-30 microgram) close-arterially into the sinus node artery produced positive chronotropic and inotropic effect which was not statistically significant. We conclude that PGI2 and PGE2 produce a negative chronotropic effect which is due to increased vagal activity and that these agents have no direct cardiac stimulatory effects in the anesthetized dog.
Similar articles
-
Prostacyclin (PGI2) induces coronary vasodilatation in anaesthetised dogs.Cardiovasc Res. 1978 Dec;12(12):720-30. Cardiovasc Res. 1978. PMID: 376143
-
Bradycardic effect of alinidine on in situ and on isolated, blood-perfused heart preparations of dogs.Arch Int Pharmacodyn Ther. 1988 Jan-Feb;291:41-54. Arch Int Pharmacodyn Ther. 1988. PMID: 2835022
-
Prostacyclin and prostaglandin E2 effects on adrenergic transmission in the kidney of anesthetized dog.J Pharmacol Exp Ther. 1981 Sep;218(3):588-92. J Pharmacol Exp Ther. 1981. PMID: 6167710
-
Prostacyclin can either increase or decrease heart rate depending on the basal state.Br J Pharmacol. 1982 Jan;75(1):243-9. doi: 10.1111/j.1476-5381.1982.tb08779.x. Br J Pharmacol. 1982. PMID: 7042022 Free PMC article.
-
Cardiovascular effects of atrial natriuretic extract in the whole animal.Fed Proc. 1986 Jun;45(7):2111-4. Fed Proc. 1986. PMID: 2940119 Review.
Cited by
-
The cardiovascular and platelet effects of epoprostenol (prostacyclin, PGI2) are unaffected by beta-adrenoceptor blockade in man.Br J Clin Pharmacol. 1982 Sep;14(3):369-77. doi: 10.1111/j.1365-2125.1982.tb01993.x. Br J Clin Pharmacol. 1982. PMID: 6127095 Free PMC article. Clinical Trial.
-
Blockade or deletion of transient receptor potential vanilloid 4 (TRPV4) is not protective in a murine model of sepsis.F1000Res. 2015 Apr 20;4:93. doi: 10.12688/f1000research.6298.1. eCollection 2015. F1000Res. 2015. PMID: 26064477 Free PMC article.
-
Prostacyclin prevents ventricular fibrillation in a canine model of sudden cardiac death.Basic Res Cardiol. 1986 Jan-Feb;81(1):40-53. doi: 10.1007/BF01907426. Basic Res Cardiol. 1986. PMID: 3521579